Basic information about inhibitors

IPAD-DB ID	C01257
Name	β-Sitosterol
Category	Natural compounds
2D Structure
3D Structure
Molecular Formula	C 2 9 H 5 0 O
Molecular Weight	414.7 g/mol
IUPAC Name	(3S, 8S, 9S, 10R, 13R, 14S, 17R)-17-[(2R, 5R)-5-ethyl-6-methylheptan-2-yl]-10, 13-dimethyl-2, 3, 4, 7, 8, 9, 11, 12, 14, 15, 16, 17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChI	InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22, 5)27(24)15-17-29(25, 26)6/h10, 19-21, 23-27, 30H, 7-9, 11-18H2, 1-6H3/t20-, 21-, 23+, 24+, 25-, 26+, 27+, 28+, 29-/m1/s1
InChIKey	KZJWDPNRJALLNS-VJSFXXLFSA-N
Canonical SMILES	CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C
PubChem CID	222284
DrugBank Accession Number	DB14038
CAS Registry Number	83-46-5

Biological activity data

Ki	-
EC50	-
IC50	-
Inhibition	-
Toxicity	-
ROS(reactive oxygen species)	-
Metal Chelating	-
BBB(blood-brain barrier)	-
Target Protein	β-site amyloid precursor protein cleaving enzyme 1 (BACE1)
Effects	Rescue spatial and recognition memory deficits in APP/PS1 mice, rescues Aβ pathology in APP/PS1 mice, attenuate Aβ accumulation and BACE-1 expression
Research Models	In APP/PS1 and WT mice
Main Source	In plants
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)	414.71
Hac(Computed by SwissADME)	30
Volume(Computed by ADMETlab 2.0)	482.068
Density(Computed by ADMETlab 2.0)	0.86
nRing(Computed by ADMETlab 2.0)	4
MaxRing(Computed by ADMETlab 2.0)	17
nHet(Computed by ADMETlab 2.0)	1
fChar(Computed by ADMETlab 2.0)	0
nRig(Computed by ADMETlab 2.0)	20
Flexibility(Computed by ADMETlab 2.0)	0.3
Stero Centers(Computed by ADMETlab 2.0)	9
LogS(Computed by ADMETlab 2.0)	-7.052
LogD(Computed by ADMETlab 2.0)	6.329

ADMET properties

logP(Computed by ADMETlab 2.0)	7.663
TPSA(Computed by SwissADME)	20.23
Hbond Acceptor(Computed by SwissADME)	1
Hbond Donor(Computed by SwissADME)	1
Rotatable Bonds(Computed by SwissADME)	6

Pharmacokinetics

GI Absorption(Computed by SwissADME)	Low
BBB(blood-brain barrier) Permeant(Computed by SwissADME)	No
P-gp Substrate(Computed by SwissADME)	No
CYP1A2 Inhibitor(Computed by SwissADME)	No
CYP2C19 Inhibitor(Computed by SwissADME)	No
CYP2C9 Inhibitor(Computed by SwissADME)	No
CYP2D6 Inhibitor(Computed by SwissADME)	No
CYP3A4 Inhibitor(Computed by SwissADME)	No
log Kp(Skin Permeation)(Computed by SwissADME)	-2.2

Druglikeness

Lipinski(Computed by SwissADME)	1
Ghose(Computed by SwissADME)	3
Veber(Computed by SwissADME)	0
Egan(Computed by SwissADME)	1
Muegge(Computed by SwissADME)	2
Bioavailability Score(Computed by SwissADME)	0.55